**Core Concept**
Small cell carcinoma of the lung is a highly aggressive neuroendocrine tumor characterized by rapid growth and early metastasis. It is often associated with paraneoplastic syndromes due to the production of various peptides and hormones by the tumor cells.

**Why the Correct Answer is Right**
The correct answer is a marker that is often elevated in small cell lung cancer (SCLC) due to the tumor's neuroendocrine origin. This marker is a protein that is produced by the tumor cells and can be detected in the blood or tissue samples. The elevated levels of this marker are associated with the diagnosis and prognosis of SCLC. The production of this marker is a result of the aberrant expression of certain genes in the tumor cells, leading to the uncontrolled production of the protein.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while it is a marker of various cancers, it is not specifically associated with small cell lung cancer.
**Option B:** Incorrect because it is a marker of ovarian cancer, not small cell lung cancer.
**Option C:** Incorrect because it is a marker of colorectal cancer, not small cell lung cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that small cell lung cancer often presents with paraneoplastic syndromes, such as Cushing's syndrome, SIADH, or Eaton-Lambert syndrome, due to the tumor's ability to produce various peptides and hormones. These syndromes can be a clue to the diagnosis of SCLC.

**Correct Answer: A. Pro-gastrin-releasing peptide (Pro-GRP) / GRP.